Dell Faulkingham's Insider Trades & SAST Disclosures
Dell Faulkingham's most recent trade in Akebia Therapeutics Inc. was a trade of 200,000 Employee Stock Option (Right to buy) done . Disclosure was reported to the exchange on Feb. 28, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Dell Faulkingham.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | Dell Faulkingham | SVP, CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 200,000 | 200,000 | - | - | Employee Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Dell Faulkingham | SVP, CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 50,000 | 180,546 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | Dell Faulkingham | SVP, CCO | Sale of securities on an exchange or to another person at price $ 2.15 per share. | 28 Feb 2022 | 6,479 | 130,546 (0%) | 0% | 2.2 | 13,961 | Common Stock |
| Akebia Therapeutics Inc. | Dell Faulkingham | SVP, CCO | Sale of securities on an exchange or to another person at price $ 2.17 per share. | 28 Feb 2022 | 5,748 | 174,798 (0%) | 0% | 2.2 | 12,477 | Common Stock |
| Akebia Therapeutics Inc. | Dell Faulkingham | SVP, CCO | Sale of securities on an exchange or to another person at price $ 2.17 per share. | 28 Feb 2022 | 957 | 173,841 (0%) | 0% | 2.2 | 2,077 | Common Stock |
| Akebia Therapeutics Inc. | Dell Faulkingham | SVP, CCO | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 01 Apr 2021 | 952 | 137,025 (0%) | 0% | 3.4 | 3,237 | Common Stock |
| Akebia Therapeutics Inc. | Dell Faulkingham | CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 9,152 | 137,977 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | Dell Faulkingham | CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 110,000 | 110,000 | - | - | Employee Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Dell Faulkingham | CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 62,000 | 135,574 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | Dell Faulkingham | CCO | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 26 Feb 2021 | 6,749 | 128,825 (0%) | 0% | 3.4 | 22,920 | Common Stock |
| Akebia Therapeutics Inc. | Dell Faulkingham | CCO | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 01 Jun 2020 | 6,426 | 73,574 (0%) | 0% | 11.6 | 74,413 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges